Radioactive hope: new drug targets Hard-to-Treat brain lymphoma
Disease control
Recruiting now
This early-phase trial tests a radioactive drug called [90Y]Y-PentixaTher in 15 people with recurrent or refractory central nervous system (CNS) lymphoma. The drug is given once through a vein, and researchers will check safety, where the drug goes in the body, and whether it shr…
Phase: PHASE1, PHASE2 • Sponsor: Pentixapharm AG • Aim: Disease control
Last updated May 17, 2026 11:33 UTC